Celldex Therapeutics (CLDX) PT Raised to $57 at Morgan Stanley
Tweet Send to a Friend
(Updated - September 23, 2026 6:20 AM EDT)
Morgan Stanley analyst Judah Frommer raised the price target on Celldex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Judah Frommer raised the price target on Celldex ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
